Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase NA 1Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 8Lung Neoplasms 8Triple Negative Breast Neoplasms 5Neoplasm Metastasis 5Multiple Myeloma 5Melanoma 5Carcinoma, Non-Small-Cell Lung 5Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Glioblastoma 4Colorectal Neoplasms 4Urinary Bladder Neoplasms 3Pancreatic Neoplasms 3Glioma 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Hepatocellular 3Burkitt Lymphoma 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Ovarian Neoplasms 2Oligodendroglioma 2Neuroblastoma 2Meningioma 2Lymphoma, B-Cell 2Endometrial Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Merkel Cell 2Astrocytoma 2Adenocarcinoma of Lung 2

Interventions

Rituximab 17Cyclophosphamide 9fludarabine phosphate 8Peripheral Blood Stem Cell Transplantation 7Lenalidomide 6Filgrastim 6Mycophenolic Acid 5ibritumomab tiuxetan 4Whole-Body Irradiation 4Indium 4Everolimus 4Bortezomib 4romidepsin 3Sirolimus 3Etoposide 3Cyclosporine 3temsirolimus 2bazlitoran 2alvocidib 2Tacrolimus 2Radiotherapy 2Prednisone 2Methotrexate 2In Situ Hybridization, Fluorescence 2Ifosfamide 2Gene Expression Profiling 2Carboplatin 2Busulfan 2Biopsy 2Antilymphocyte Serum 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Waldenstrom Macroglobulinemia × Magnetic Resonance Spectroscopy × Clear all
NCT07420959 2026-02-19

ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia

Mayo Clinic

Phase 1/2 Not yet recruiting
38 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡